Senti Biosciences, Inc. Quarterly Operating Margin in % from Q4 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Senti Biosciences, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q2 2024.
  • Senti Biosciences, Inc. Operating Margin for the quarter ending June 30, 2024 was -27.3K %, a 1781% decline year-over-year.
  • Senti Biosciences, Inc. annual Operating Margin for 2023 was -3.62K %, a 150% decline from 2022.
  • Senti Biosciences, Inc. annual Operating Margin for 2022 was -1.45K %, a 1.12% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -27.3K -25.8K -1781% Apr 1, 2024 Jun 30, 2024
Q1 2024 -7.38K -5.92K -405% Jan 1, 2024 Mar 31, 2024
Q4 2023 -3.62K -2.17K -150% Oct 1, 2023 Dec 31, 2023
Q3 2023 -3.35K Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.45K Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.46K Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.45K Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.